---
title: 1.1 Class members
---

import Expander from '../../../src/components/Expander'



<table>
 <tr>
  <th>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </th>
  <th>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </th>
  <th>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </th>
  <th>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </th>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td rowspan="5">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td rowspan="2">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
  <td>
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
 <tr>
  <td colspan="4">
   <p>
    <strong>
     Benzodiazepine
    </strong>
   </p>
   <p>
    <strong>
     Licensed indications
    </strong>
    *
   </p>
   <p>
    <strong>
     Formulations
    </strong>
   </p>
   <p>
    <strong>
     Strengths
    </strong>
   </p>
   <p>
    alprazolam
   </p>
   <p>
    Moderate to severe anxiety states; anxiety associated with depression
   </p>
   <p>
    Tablets
   </p>
   <p>
    250 micrograms, 500 micrograms
   </p>
   <p>
    chlordiazepoxide
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; muscle spasm; alcohol withdrawal
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg, 10 mg
   </p>
   <p>
    clobazam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; anxiety associated with depression (in conjunction with other treatment); adjunctive therapy of epilepsy
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg
   </p>
   <p>
    clonazepam
   </p>
   <p>
    Epileptic disease
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 2 mg
   </p>
   <p>
    Status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    diazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; cerebral palsy; muscle spasm; adjunctive treat­ment of epilepsy; alcohol withdrawal; premedi­cation before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    2 mg, 5 mg, 10 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    2 mg/5 ml, 5 mg/5 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; muscle spasm (eg in tetanus or poisoning); status epilepticus; severe acute anxiety or agitation (eg delirium tremens)
   </p>
   <p>
    Injection solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Injection emulsion
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    2 ml
   </p>
   <p>
    Severe acute anxiety or agitation; convulsions; muscle spasm (eg in tetanus or poisoning); sedation before medical procedures
   </p>
   <p>
    Rectal solution
   </p>
   <p>
    <strong>
     2 mg/ml:
    </strong>
    1.25 ml, 2.5 ml
    <strong>
     <br/>
     4 mg/ml:
    </strong>
    2.5 ml
   </p>
   <p>
    flurazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Capsules
   </p>
   <p>
    15 mg, 30 mg
   </p>
   <p>
    loprazolam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg
   </p>
   <p>
    lorazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety; premedication before dental procedures or before surgery
   </p>
   <p>
    Tablets
   </p>
   <p>
    1 mg, 2.5 mg
   </p>
   <p>
    Premedication before medical procedures; acute anxiety, excitement or mania; status epilepticus
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     4 mg/ml:
    </strong>
    1 ml
   </p>
   <p>
    lormetazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    500 micrograms, 1 mg
   </p>
   <p>
    midazolam
   </p>
   <p>
    Acute prolonged convulsive seizures
   </p>
   <p>
    Oromucosal solution
   </p>
   <p>
    <strong>
     5 mg/ml:
    </strong>
    0.5 ml, 1 ml, 1.5 ml, 2 ml
   </p>
   <p>
    Sedation before medical procedures; premedication before surgery; induction of anaesthesia; sedative in combined anaesthesia; sedation for patients in intensive care
   </p>
   <p>
    Injection
   </p>
   <p>
    <strong>
     1 mg/ml:
    </strong>
    2 ml, 5 ml, 10 ml
    <strong>
     <br/>
     2 mg/ml:
    </strong>
    5 ml, 25 ml, 50 ml
    <strong>
     <br/>
     5 mg/ml:
    </strong>
    1 ml, 2 ml, 3 ml, 5 ml, 10 ml
   </p>
   <p>
    nitrazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia
   </p>
   <p>
    Tablets
   </p>
   <p>
    5 mg
   </p>
   <p>
    Oral suspension
   </p>
   <p>
    2.5 mg/5 ml
   </p>
   <p>
    oxazepam
   </p>
   <p>
    Disabling or unacceptably distressing anxiety
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 15 mg
   </p>
   <p>
    temazepam
   </p>
   <p>
    Disabling or unacceptably distressing insomnia; premedication before medical procedures
   </p>
   <p>
    Tablets
   </p>
   <p>
    10 mg, 20 mg
   </p>
   <p>
    Oral solution
   </p>
   <p>
    10 mg/5 ml
   </p>
   <p>
    *Consult summaries of product characteristics for up to date statements on authorised indications
   </p>
  </td>
 </tr>
</table>


  
<Expander title="Did you know...">
 <p>
  Diazepam is absorbed more rapidly and less erratically from oral tablets than from intramuscular injection. If rapid effect is needed, it is best to give diazepam either intravenously or as a rectal solution. Alternatives to diazepam include lorazepam by intravenous injection and oromucosal (‘buccal’) tablets of midazolam.
 </p>
</Expander>





